<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> permeability transition (MPT) is an intracellular event that is closely related to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and <z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, whether this process underlies the recently reported neuroprotective potency of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="120" ids="26216">potassium</z:chebi> channel openers applied in vivo remains uncertain </plain></SENT>
<SENT sid="2" pm="."><plain>This study aims to clarify this issue by determining the effects of <z:chebi fb="120" ids="26216">potassium</z:chebi> channel openers on MPT dynamics in vitro along with their in vivo effects </plain></SENT>
<SENT sid="3" pm="."><plain>Male Sprague-Dawley rats were subjected to middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) for 90 min, followed by reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>30&amp;#956;l of <z:chebi fb="0" ids="4495">diazoxide</z:chebi>, an opener of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="3" ids="15422">adenosine triphosphate</z:chebi>-sensitive K&lt;sup&gt;+&lt;/sup&gt;channel (mitoK&lt;inf&gt;ATP&lt;/inf&gt;), or NS1619, an opener of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> Ca&lt;sup&gt;2+&lt;/sup&gt;-activated <z:chebi fb="120" ids="26216">potassium</z:chebi> channel (mitoK&lt;inf&gt;Ca&lt;/inf&gt;) (2 mM and 0.1 mM respectively), was infused into the right lateral cerebral ventricle 15 min before the induction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Neurological scores were assessed 24 h after MCAO and then <z:mpath ids='MPATH_124'>infarct</z:mpath> area was determined by standard 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining techniques </plain></SENT>
<SENT sid="6" pm="."><plain>To further clarify the capacity of <z:chebi fb="0" ids="4495">diazoxide</z:chebi> and NS1619 to protect mitochondria from Ca&lt;sup&gt;2+&lt;/sup&gt;-induced MPT, we isolated brain-derived non-synaptosomal mitochondria and evaluated the effects of <z:chebi fb="0" ids="4495">diazoxide</z:chebi> and NS1619 on Ca&lt;sup&gt;2+&lt;/sup&gt;-induced MPT dynamics through measurement of spectrophotometric alterations in light scattering at 520 nm </plain></SENT>
<SENT sid="7" pm="."><plain>Neurological scores and <z:mpath ids='MPATH_124'>infarct</z:mpath> size were improved in animals pretreated with <z:chebi fb="0" ids="4495">diazoxide</z:chebi> and NS1619 </plain></SENT>
<SENT sid="8" pm="."><plain>In isolated mitochondria, MPT was readily induced by 200 &amp;#956;M Ca&lt;sup&gt;2+&lt;/sup&gt;and was effectively inhibited by <z:chebi fb="0" ids="4495">diazoxide</z:chebi> and NS1619 </plain></SENT>
<SENT sid="9" pm="."><plain>The specific MPT pore opener atractyloside abolished the inhibitory effects </plain></SENT>
<SENT sid="10" pm="."><plain>According to time-constant analysis, MPT dynamics was in accordance with the neuroprotective effects of channel openers in vivo </plain></SENT>
</text></document>